Akebia Therapeutics, Inc. ($AKBA)
Filing Information
| Accession Number | 0002107264-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
69,772
Total Value
$96,983.08
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Legal Officer | Common Stock | โ | Feb 2, 2026 | Sale | 16,846 | $1.39 | $23,415.94 | 641,304 | Direct | โ | View Details | |
SVP, Chief Legal Officer | Common Stock | โ | Feb 2, 2026 | Sale | 25,382 | $1.39 | $35,280.98 | 615,922 | Direct | โ | View Details | |
SVP, Chief Legal Officer | Common Stock | โ | Feb 2, 2026 | Sale | 27,544 | $1.39 | $38,286.16 | 588,378 | Direct | โ | View Details |